Notice for International Patients & Caregivers
English summary does not mean the trial enrolls international patients. Multiple myeloma interventional clinical trials in China typically require valid Chinese resident identity/national healthcare insurance and strict adherence to China's Human Genetic Resources Administration regulations.
Gansu Multiple Myeloma Active Trials & Centers
As of 2026-09-04, there are 6 active clinical trials for multiple myeloma hosted across 3 tertiary medical centers in Gansu (including The First Hospital of Lanzhou University, Gansu Provincial Hospital, Gansu Provincial Cancer Hospital).
Participating Medical Centers (3)
Active Studies in Gansu (6)
Population synthesized by CMDNShowing 0 published English records of 6 registry trials.
All 6 local registry studies currently have Chinese-only filings. Verified English summaries will be published upon regulatory audit.